Published in Circulation on April 04, 2005
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 2.96
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet (2010) 2.24
Renal denervation in moderate to severe CKD. J Am Soc Nephrol (2012) 2.21
Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med (2008) 2.00
Assessment and management of blood-pressure variability. Nat Rev Cardiol (2013) 1.84
Impact of white-coat hypertension on microvascular complications in type 2 diabetes. Diabetes Care (2008) 1.45
Central blood pressure: current evidence and clinical importance. Eur Heart J (2014) 1.43
Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens (2012) 1.35
Risk stratification by self-measured home blood pressure across categories of conventional blood pressure: a participant-level meta-analysis. PLoS Med (2014) 1.29
Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study. Hypertens Res (2012) 1.22
Principles and techniques of blood pressure measurement. Cardiol Clin (2010) 1.20
Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension (2014) 1.18
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks. J Hum Hypertens (2013) 1.10
Role of ambulatory and home blood pressure recording in clinical practice. Curr Cardiol Rep (2009) 1.09
Physical exercise, fitness and dietary pattern and their relationship with circadian blood pressure pattern, augmentation index and endothelial dysfunction biological markers: EVIDENT study protocol. BMC Public Health (2010) 1.08
Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol (2011) 1.03
Effects of education on self-monitoring of blood pressure based on BASNEF model in hypertensive patients. J Res Med Sci (2010) 1.01
A 15-year longitudinal study on ambulatory blood pressure tracking from childhood to early adulthood. Hypertens Res (2009) 0.99
Pressure natriuresis and the renal control of arterial blood pressure. J Physiol (2014) 0.98
Hypertension treatment and control rates: chart review in an academic family medicine clinic. Can Fam Physician (2009) 0.97
Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review. Ann Intern Med (2015) 0.97
Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol. BMC Public Health (2010) 0.96
Can nocturnal hypertension predict cardiovascular risk? Integr Blood Press Control (2009) 0.96
Home blood pressure monitoring: how good a predictor of long-term risk? Curr Hypertens Rep (2011) 0.95
Nocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patients. J Hypertens (2009) 0.94
Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker. Clin Exp Nephrol (2009) 0.94
Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis (2012) 0.94
Nocturnal hypoxemia and periodic limb movement predict mortality in patients on maintenance hemodialysis. Clin J Am Soc Nephrol (2010) 0.93
The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO): moving from baseline characteristics to research perspectives. Hypertens Res (2012) 0.92
Clinical implications of ambulatory and home blood pressure monitoring. Korean Circ J (2010) 0.91
Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension (2012) 0.91
Peripheral and central arterial pressure and its relationship to vascular target organ damage in carotid artery, retina and arterial stiffness. Development and validation of a tool. The Vaso risk study. BMC Public Health (2011) 0.90
Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers. Arch Med Sci (2013) 0.88
Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis. Blood Press Monit (2011) 0.87
Blood pressure reverse-dipping is associated with early formation of carotid plaque in senior hypertensive patients. Medicine (Baltimore) (2015) 0.87
Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk. J Hypertens (2014) 0.86
Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study. Int J Cardiol (2013) 0.86
Inhibitory effects of azelnidipine tablets on morning hypertension. Drugs R D (2013) 0.86
Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently? Vasc Health Risk Manag (2013) 0.86
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide. J Clin Hypertens (Greenwich) (2010) 0.85
Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting. Ann Fam Med (2008) 0.85
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension (2016) 0.84
Evaluation of the Use of Home Blood Pressure Measurement Using Mobile Phone-Assisted Technology: The iVitality Proof-of-Principle Study. JMIR Mhealth Uhealth (2016) 0.84
Prevalence and factors affecting home blood pressure documentation in routine clinical care: a retrospective study. BMC Health Serv Res (2010) 0.83
Novel mechanism for disrupted circadian blood pressure rhythm in a rat model of metabolic syndrome--the critical role of angiotensin II. J Am Heart Assoc (2013) 0.83
Social support and nocturnal blood pressure dipping: a systematic review. Am J Hypertens (2013) 0.82
Pragmatic Method Using Blood Pressure Diaries to Assess Blood Pressure Control. Ann Fam Med (2016) 0.82
Primary non-alcoholic fatty liver disease in hypertensive patients. Australas Med J (2013) 0.81
Socioeconomic status, nocturnal blood pressure dipping, and psychosocial factors: a cross-sectional investigation in Mexican-American women. Ann Behav Med (2012) 0.81
Differences between clinic blood pressure and morning home blood pressure, as shown by Bland-Altman plots, in a large observational study (HONEST study). Hypertens Res (2015) 0.81
Maternal clinic and home blood pressure measurements during pregnancy and infant birth weight: the BOSHI study. Hypertens Res (2015) 0.81
Effects of age on arterial stiffness and blood pressure variables in patients with newly diagnosed untreated hypertension. Korean Circ J (2015) 0.80
Should white-coat hypertension in diabetes be treated? Pro. Diabetes Care (2009) 0.80
Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension. BMC Cardiovasc Disord (2011) 0.80
Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure. Clin Exp Nephrol (2009) 0.79
Out-of-office blood pressure: from measurement to control. Integr Blood Press Control (2012) 0.79
Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens (2015) 0.79
Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study. BMC Nephrol (2012) 0.79
Home blood pressure monitoring: Australian Expert Consensus Statement. J Hypertens (2015) 0.79
Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension? Clin Exp Nephrol (2015) 0.78
What is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease? BMC Med (2015) 0.78
Chronic kidney disease is characterized by "double trouble" higher pulse pressure plus night-time systolic blood pressure and more severe cardiac damage. PLoS One (2014) 0.78
Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore) (2015) 0.78
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial. J Hypertens (2014) 0.78
Treatment strategies for osteoarthritis patients with pain and hypertension. Ther Adv Musculoskelet Dis (2010) 0.77
Preventing vascular effects on brain injury and cognition late in life: knowns and unknowns. Neuropsychol Rev (2014) 0.77
Azilsartan Improves Salt Sensitivity by Modulating the Proximal Tubular Na+-H+ Exchanger-3 in Mice. PLoS One (2016) 0.76
Telemedicine home blood pressure measurements and progression of albuminuria in elderly people with diabetes. Hypertension (2008) 0.76
Cerebral microbleeds are associated with nocturnal reverse dipping in hypertensive patients with ischemic stroke. BMC Neurol (2014) 0.76
The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension. Arch Med Sci (2014) 0.76
Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries. Cardiol Clin (2017) 0.75
Persistent olmesartan-based blood pressure-lowering effects on morning hypertension in Asians: the HONEST study. Hypertens Res (2016) 0.75
Letter regarding article by Sega et al, "Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population". Circulation (2005) 0.75
Renal sympathetic nervous system and the effects of denervation on renal arteries. World J Cardiol (2014) 0.75
Ambulatory Blood Pressure Monitoring: Five Decades of More Light and Less Shadows. Arq Bras Cardiol (2016) 0.75
Letter regarding article by Sega et al, "Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population". Circulation (2005) 0.75
High Short-Term Blood Pressure Variability Predicts Long-Term Cardiovascular Mortality in Untreated Hypertensives But Not in Normotensives. Am J Hypertens (2016) 0.75
Practical use of home blood pressure monitoring in chronic kidney disease. Cardiorenal Med (2014) 0.75
Home blood pressure and cardiovascular risk in treated hypertensive patients: the prognostic value of the first and second measurements and the difference between them in the HONEST study. Hypertens Res (2016) 0.75
Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data. BMJ Open (2014) 0.75
Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients. BMC Cardiovasc Disord (2016) 0.75
Relevance to home blood pressure monitoring protocol of blood pressure measurements taken before first- morning micturition and in the afternoon. Arq Bras Cardiol (2014) 0.75
Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood Pressure. Cardiol Ther (2015) 0.75
Home monitoring of blood pressure. Aust Prescr (2015) 0.75
Prevalence of Masked Hypertension: a Population-Based Survey in a Large City by Using 24-Hour Ambulatory Blood Pressure Monitoring. Korean Circ J (2016) 0.75
Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Med Arch (2016) 0.75
Clinical Practice of Two Measurements of Home Blood Pressure on Each Occasion in Patients with Chronic Kidney Disease. Cardiorenal Med (2015) 0.75
Letter regarding article by Sega et al, "Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population". Circulation (2005) 0.75
A comparison study of brachial blood pressure recorded with Spacelabs 90217A and Mobil-O-Graph NG devices under static and ambulatory conditions. J Hum Hypertens (2016) 0.75
Clinical significance of home blood pressure and its possible practical application. Clin Exp Nephrol (2013) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985) (2006) 11.52
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med (2006) 5.18
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
The charity and the care: the origin and the evolution of hospitals. Eur J Intern Med (2012) 4.76
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension (2006) 3.60
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens (2011) 3.50
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension (2007) 2.94
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension (2009) 2.71
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension (2006) 2.65
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf (2010) 2.57
Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol (2011) 2.40
Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension (2011) 2.32
Seasonal blood pressure changes: an independent relationship with temperature and daylight hours. Hypertension (2013) 2.30
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation (2002) 2.29
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. Am J Hypertens (2013) 2.27
Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens (2014) 2.25
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet (2010) 2.24
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation (2012) 2.21
Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension (2002) 2.15
The contribution of major risk factors and job strain to occupational class differences in coronary heart disease incidence: the MONICA Brianza and PAMELA population-based cohorts. Occup Environ Med (2010) 2.11
Enhanced baroreceptor control of the cardiovascular system by polyunsaturated Fatty acids in heart failure patients. J Am Coll Cardiol (2006) 2.09
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes Care (2013) 2.07
Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension (2005) 2.05
The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens (2002) 2.03
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation (2002) 1.95
Failure of monolateral renal nerve ablation to exert sympathoinhibitory and blood pressure lowering effects in a patient with resistant hypertension: a case report. Int J Cardiol (2013) 1.91
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study. Hypertension (2004) 1.90
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol (2005) 1.88
Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension (2013) 1.87
Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol (2004) 1.82
Risk of non-Hodgkin lymphoma in celiac disease. JAMA (2002) 1.81
The sympathetic nervous system and the metabolic syndrome. J Hypertens (2007) 1.80
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension (2007) 1.77
Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice. Hypertension (2011) 1.73
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension (2007) 1.71
Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic parents. Hypertension (2008) 1.71
Blood pressure variability and silent cerebral damage in essential hypertension. Am J Hypertens (2004) 1.69
Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol (2009) 1.68
Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J (2013) 1.66
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension (2008) 1.65
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney Int (2012) 1.63
Methods and devices for measuring arterial compliance in humans. Am J Hypertens (2002) 1.61
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension (2009) 1.56
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? Am J Hypertens (2008) 1.55
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension (2005) 1.54